Under the licensing agreement, Pfizer will not receive royalties from the manufacturers, making the treatment cheaper
US pharmaceutical giant Pfizer has announced a deal to make its prospective antiviral Covid-19 pill available more cheaply in the world’s least-wealthy countries.
Pfizer will allow generic manufacturers to supply its promising Paxlovid pill to 95 low-and middle-income nations covering about 53% of the world’s population, the company said in a statement on Tuesday.
Continue reading…
Source: The Guardian